← Evidence map

ArticleAntibody therapeutics2026

IMM2510, a novel anti-PD-L1/VEGF bispecific antibody for cancer immunotherapy.

Dianze Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41804385